Get access to our best features
Get Started
Subscribe
Israel-Hamas Conflict
2024 US Election
NFL
Baseball
US Politics
Joe Biden
Tornado
Donald Trump
US Economy
US Crime
Patriots
US Social Issues
David Pecker
Get access to our best features
Get Started
Published 3 years ago

Pfizer’s coronavirus vaccine is more than 90 percent effective in first analysis, company reports

Summary by The Gazette
A front-runner coronavirus vaccine developed by drug giant Pfizer and German biotechnology firm BioNTech was more than 90 percent effective at protecting people compared with a placebo saline shot, according to an interim analysis by an independent data monitoring committee that met Sunday.

0 Articles

All
Left
Center
Right
Times of IndiaTimes of India

Pfizer, BioNTech say their COVID-19 vaccine is more than 90% effective

"Today is a great day for science and humanity," Albert Bourla, Pfizer's chairman and chief executive, said.

3 years ago·India
Read Full Article
BBC NewsBBC News

Covid vaccine: First 'milestone' vaccine offers 90% protection

The vaccine is a "significant step" forward for getting life back to normal, but challenges remain.

3 years ago·United Kingdom
Read Full Article
Yahoo NewsYahoo News

Pfizer, BioNTech say their COVID-19 vaccine is more than 90% effective

Pfizer Inc on Monday said its experimental vaccine was more than 90% effective in preventing COVID-19 based on initial data from a large study, a major victory in the fight against a pandemic that has killed over 1 million people, roiled the world's economy and upended daily life. Pfizer and German partner BioNTech SE are the first drugmakers to show successful data from a large-scale clinical trial of a coronavirus vaccine. If authorized, the…

3 years ago·Los Angeles, United States
Read Full Article
News18 IndiaNews18 India

'Step Closer to Ending Global Health Crisis': Pfizer Says its Covid-19 Vaccine 90% Effective in Phase 3 Trial

Protection in patients was achieved seven days after the second of two doses, and 28 days after the first, according to preliminary findings.

3 years ago·India
Read Full Article
The GuardianThe Guardian

Covid-19 vaccine candidate is 90% effective, says manufacturer

Interim analysis of vaccine by Pfizer/BioNTech far exceeds expectations of most experts

3 years ago·London, United Kingdom
Read Full Article
The HinduThe Hindu

Pfizer says COVID-19 vaccine 90% effective in Phase 3 trial

Protection in patients was achieved seven days after the second of two doses, and 28 days after the first, according to preliminary findings.

3 years ago·India
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 55% of the sources are Center
54% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

EuropeEurope
BusinessBusiness
Middle EastMiddle East
VaccinationsVaccinations
NatureNature
AsiaAsia
InternationalInternational
Trending Topics
Ground News logo
US
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble Newsletter
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc.
News
For You
Search
BlindspotLocal